Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AroCell AB

AROC
Current price
0.5 SEK +0.002 SEK (+0.40%)
Last closed 0.5 SEK
ISIN SE0003883990
Sector Healthcare
Industry Diagnostics & Research
Exchange Stockholm Exchange
Capitalization 116 962 132 SEK
Yield for 12 month +0.81 %
1Y
3Y
5Y
10Y
15Y
AROC
21.11.2021 - 28.11.2021

AroCell AB (publ), a vitro diagnostics company, develops and markets blood and urine sample test products for use in the treatment of breast, prostate, and bladder cancers. The company provides AroCell TK 210 ELISA, an immunoassay kit for the determination of human Thymidine Kinase 1 protein concentration in blood samples; and UBC Rapid for diagnosing and monitoring bladder cancer patients. It also offers TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden. Address: Karlsbodavägen 39, Stockholm, Sweden, 168 67

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.72 SEK

P/E ratio

Dividend Yield

Current Year

+42 847 786 SEK

Last Year

+36 821 669 SEK

Current Quarter

+13 933 816 SEK

Last Quarter

+15 205 141 SEK

Current Year

-2 092 663 SEK

Last Year

-2 095 652 SEK

Current Quarter

+3 064 328 SEK

Last Quarter

+2 762 666 SEK

Key Figures AROC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 927 197 SEK
Operating Margin TTM -87.22 %
PE Ratio
Return On Assets TTM -19.13 %
PEG Ratio
Return On Equity TTM -32.22 %
Wall Street Target Price 12.72 SEK
Revenue TTM 48 072 465 SEK
Book Value 0.71 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 29.7 %
Dividend Yield
Gross Profit TTM -2 095 648 SEK
Earnings per share -0.23 SEK
Diluted Eps TTM -0.23 SEK
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -111.28 %

Dividend Analytics AROC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AROC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AROC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.3767
Price Sales TTM 2.4092
Enterprise Value EBITDA -1.3417
Price Book MRQ 0.8224

Financials AROC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AROC

For 52 weeks

0.3 SEK 0.66 SEK
50 Day MA 0.55 SEK
Shares Short Prior Month
200 Day MA 0.44 SEK
Short Ratio
Shares Short
Short Percent